Back to Search Start Over

755 100% Svr4 and Favorable Safety of Abt-493 + Abt-530 Administered for 12 Weeks in Non-Cirrhotic Patients With Genotypes 4, 5, or 6 Infection (Surveyor-I).

Authors :
Gane, Edward
Lalezari, Jacob
Asatryan, Armen
Greenbloom, Susan
Hassanein, Tarek I.
Ng, Teresa
Liu, Ran
Lin, Chih-Wei
Kort, Jens
Mensa, Federico
Source :
Gastroenterology (00165085); Apr2016 Supplement 1, Vol. 150, pS1047-S1047, 1p
Publication Year :
2016

Details

Language :
English
ISSN :
00165085
Volume :
150
Database :
Supplemental Index
Journal :
Gastroenterology (00165085)
Publication Type :
Academic Journal
Accession number :
114622358
Full Text :
https://doi.org/10.1016/S0016-5085(16)33540-5